Pegylated liposomal doxorubicin
Drug timelines are a Plus or Pro feature.
56 regulatory and trial events tracked for Pegylated liposomal doxorubicin, covering 2007-11-16 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer [Phase 2]